0000001 - Document - COVER PAGE link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952156 - Disclosure - Organization and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - Acquisition of Soleno Therapeutics, Inc. link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Supplemental Financial Information link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Earnings per Share link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Collaboration and License Agreements link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Segment Reporting and Disaggregation of Relevant Expense Captions link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Sale of Neurocrine Group Limited link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Legal Matters link:presentationLink link:calculationLink link:definitionLink 9955511 - Disclosure - Organization and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9955512 - Disclosure - Acquisition of Soleno Therapeutics, Inc. (Tables) link:presentationLink link:calculationLink link:definitionLink 9955513 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9955514 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9955515 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9955516 - Disclosure - Supplemental Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9955517 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9955518 - Disclosure - Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9955519 - Disclosure - Segment Reporting and Disaggregation of Relevant Expense Captions (Tables) link:presentationLink link:calculationLink link:definitionLink 9955520 - Disclosure - Sale of Neurocrine Group Limited (Table) link:presentationLink link:calculationLink link:definitionLink 9955521 - Disclosure - Acquisition of Soleno Therapeutics, Inc. - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - Acquisition of Soleno Therapeutics, Inc. - Summarizes Preliminary Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - Acquisition of Soleno Therapeutics, Inc. - Preliminary Allocation of Consideration Transferred to the Assets Acquired and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955524 - Disclosure - Acquisition of Soleno Therapeutics, Inc. - Pro Forma Financial Information (unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 9955525 - Disclosure - Fair Value Measurements - Investments Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9955526 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955527 - Disclosure - Fair Value Measurements - Revenue by Major Customers by Reporting Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - Goodwill and Intangible Assets - Intangible Assets Amortized Over Estimated Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 9955530 - Disclosure - Goodwill and Intangible Assets - Estimated Annual Amortization Expense for Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9955531 - Disclosure - Debt - (Details) link:presentationLink link:calculationLink link:definitionLink 9955532 - Disclosure - Leases - Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - Leases - Operating Lease Liability Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - Leases - Operating Lease Liability Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9955534 - Disclosure - Supplemental Financial Information - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9955535 - Disclosure - Supplemental Financial Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955536 - Disclosure - Supplemental Financial Information - Prepaid Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9955537 - Disclosure - Supplemental Financial Information - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955538 - Disclosure - Supplemental Financial Information - Other Noncurrent Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955539 - Disclosure - Supplemental Financial Information - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9955540 - Disclosure - Supplemental Financial Information - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955541 - Disclosure - Stockholders’ Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955542 - Disclosure - Stockholders’ Equity - Share Repurchase Program (Details) link:presentationLink link:calculationLink link:definitionLink 9955543 - Disclosure - Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955544 - Disclosure - Collaboration and License Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955545 - Disclosure - Segment Reporting and Disaggregation of Relevant Expense Captions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955546 - Disclosure - Segment Reporting and Disaggregation of Relevant Expense Captions - Segment Reporting Information, by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9955547 - Disclosure - Sale of Neurocrine Group Limited - Assets And Liabilities Classified as Held For Sale (Details) link:presentationLink link:calculationLink link:definitionLink 9955548 - Disclosure - Sale of Neurocrine Group Limited - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink